专注转染18年, 体内转染与细胞转染整体解决方案

Bioact Mater. 2026 Jul 12;66:487-507(IF:23.6).

Cancer Res. 2026 Jan 1;86(2):349-366.(IF:22.6).

Cell Mol Immunol. 2025 Aug 20.(IF:21.8).

J Adv Res. 2025 Jun 27;82:1069-1082.(IF:17.1).

Nat Biotechnol. 2025 Apr 21;44(3):387-393.(IF:44.5).

Cell. 2025 Feb 20;188(4)(IF:66.850).

Adv Sci (Weinh). 2025 Jan 31(IF:14.3).

Autophagy. 2024 Sep 3:1-14.(IF:14.600).

Nat Commun. 2024 Aug 13;15(1)(IF:14.7).

Cell Metab. 2024 Jun 4;36(6)(IF:31.3737).

Small Methods. 2024 Jan 2:e2301310(IF:25.367).

Signal Transduct Target Ther. 2023 Aug 7 (IF:39.3).

Signal Transduct Target Ther. 2023 Apr (IF:39.3).

Cell Mol Immunol . 2022 Sep 1. (IF:22.096).

Cell Res.2021 Sep 24.(IF:25.617).

J Extracell Vesicles. 2021 Feb 18;10(4)(IF:21.7).

Mol Cancer. 2019 18(1):61.(IF:27.401).

Mol Cell . 2018 Feb 1;69(3):480-492.e7.(IF:14.714).

Nat Cell Biol. 2015 Jan;17(1):95-103. (IF:19.679).

Mol Cancer . 2014 Sep 6;13:206.(IF:37.3).